Oncology
Become a Member Today!
Register
Email
Password
Remember me
Forgot your Password?
Invite Code?
Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
Alternative Therapies
Anemia/Polycythemia
BMT/SCT
Basic Science/Genetics
Bone/Cartilage
Breast
Carcinogenesis
Coagulation/Bleeding Dz
Colorectal Cancer/Polyps
Dermatologic Oncology
Diagnostics/Radiology
Economics of Medicine
Endocrine Oncology
GI Oncology
Gynecologic Oncology
Head and Neck
Hepatobiliary/Pancreas
Leukemia/Lymphoma
Lung/Thoracic Oncology
Myeloproliferative Dz
Neurologic Oncology
Pain/Palliative Care
Pediatric Heme/Oncology
Pharmacology/Therapy
Popular Press
Renal/Urologic
Side Effects
Soft Tissue/Sarcoma
Transfusion Medicine
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Sponsor
Sponsor
For Practicing Oncologists
Cancer Science:
T-cell/tumor-cell tethering antibody shows promise against refractory non-Hodgkin's lymphoma
Sara Hartley, MDLinx Oncology
Today's Oncology News:
The HERS+ to HER2- Switch--Clinically Significant?
D Scott Cunningham MD, PhD, MDLinx Oncology
Noninvasive Biochemical Probe Uses Light to Detect Skin Cancers
Dorothy J. Schirf, MD, MDLinx Oncology
See all
Article Summary
Click the title below to leave the MDLinx Network and go to the Journal's Website
Cell Cycle Regulator Gene CDC5L, a Potential Target for 6p12-p21 Amplicon in Osteosarcoma
Molecular Cancer Research, 06/25/08
Print
Email This Article
Save in My Library
Free Abstract
Lu X-Y et al. - These results indicate that CDC5L, a cell cycle regulator important for the G2-M transition, is the most likely candidate oncogene for the 6p12-p21 amplicon found in osteosarcoma.
--- BASIC SCIENCE/GENETICS TOP ARTICLES ---
Receive free subspecialty "5-minute updates" via email
Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 08/07/08
Ixabepilone: A new antimitotic for the treatment of metastatic breast cancer
Annals of Pharmacotherapy, 08/18/08
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 08/21/08
...All of Basic Science/Genetics
Sponsor
--- BONE/CARTILAGE TOP ARTICLES ---
Receive free subspecialty "5-minute updates" via email
Quality-of-Life Assessment for Routine Oncology Clinical Practice
The Journal of Supportive Oncology, 06/16/08
Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women
Maturitas, 09/02/08
High level of mitogen-activated protein kinase phosphatase-1 expression is associated with cisplatin resistance in osteosarcoma
Pediatric Blood & Cancer, 08/27/08
...All of Bone/Cartilage
Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
Medical Students
Nurse Practitioner
Pharma/Drug Marketer
Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
All MDLinx
AllergyImmunoLinx
AnesthesiaLinx
DentistLinx
DermLinx
DrugLinx
ENTLinx
EmergencyMDLinx
EndoLinx
FamilyMDLinx
GILinx
HeartLinx
HemeOncLinx
HospitalAdminLinx
IDLinx
InternalMDLinx
MedStudentLinx
NPLinx
NephrologyLinx
NeurologyLinx
NurseLinx
ObGynLinx
OphthoLinx
OrthoLinx
PALinx
PatientLinx
PediatricLinx
PharmacistLinx
PsychLinx
PulmonologyLinx
RadiologyLinx
RheumatologyLinx
SurgeryLinx
UrologyLinx
Published within:
Past Month
Past 3 Months
Past Year
Sort By:
Date
Relevance
Sponsor
Sponsor
About MDLinx
|
Contact
|
Advertise with MDLinx
|
Site Map
|
Privacy Policy
|
Terms of Use
|
Sign Up For Newsletters
|
Recommend this Site
English
|
Español
|
Français
|
Deutsch
|
中文
|
Руccкий
|
Norsk
|
Nederlands
|
Português
|
Italiano
©1999-2008 MDLinx, Inc.